Real-time check-ins from patients with MBC showed quality of life dipped when depression, anxiety, or fatigue rose above usual levels.
Commentary|Articles|July 10, 2026
GLP-1s in Oncology: Nursing Insights and Breast Cancer Survivorship
Author(s)Alex Biese
Experts explore the clinical promise, nursing implications, and access barriers of GLP-1s in cancer care.
Advertisement
Advertisement
For Patricia Jakel, MN, RN, AOCN, an oncology nurse consultant and co-editor in chief of Oncology Nursing News, the struggle with weight gain was not a matter of willpower, but biology. Like many patients who are diagnosed with lobular breast cancer, Jakel found that the very treatments saving her life were also working against her metabolic health.
Related to this article
FDA approves tucatinib maintenance with trastuzumab and pertuzumab for HER2+ breast cancer based on HER2CLIMB-05.
Oncology nurse April Fowler shares her personal stage 4 cancer journey, reflecting on clinical empathy, patient advocacy, and oncology endurance.
A nurse-led support program significantly reduces death anxiety in women with breast cancer on hormonal therapy, study finds.
Adding atezolizumab to adjuvant FOLFOX halved the risk of recurrence or death in ATOMIC, with more grade 3 to 4 adverse events.
In observation of National PA Week, Moffitt PA Mark Honor discusses the expansion of APPs and key collaboration strategies for oncology nurses.
Beth Faiman details the new IMS/IMWG consensus definition of cure for multiple myeloma, requiring 5 years of treatment-free remission.
Advertisement
Advertisement